Gene · 3205
Papers4,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 4,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic Regulation of Angiogenesis in Development and Tumors Progression: Potential Implications for Cancer Treatment. | Front Cell Dev Biol | 2021 | 34552922 | PubTator, text mining | PubMed |
| Noncoding RNAs in pediatric brain tumors: Molecular functions and pathological implications. | Mol Ther Nucleic Acids | 2021 | 34552822 | PubTator, text mining | PubMed |
| tiRNA signaling via stress-regulated vesicle transfer in the hematopoietic niche. | Cell Stem Cell | 2021 | 34551362 | PubTator, text mining | PubMed |
| Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia. | Cell Rep | 2021 | 34551306 | PubTator, text mining | PubMed |
| DOT1L O-GlcNAcylation promotes its protein stability and MLL-fusion leukemia cell proliferation. | Cell Rep | 2021 | 34551297 | PubTator, text mining | PubMed |
| ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine. | Blood Cancer J | 2021 | 34548471 | PubTator, text mining | PubMed |
| Control of the eIF4E activity: structural insights and pharmacological implications. | Cell Mol Life Sci | 2021 | 34541613 | PubTator, text mining | PubMed |
| Roles of Histone Deacetylases in Acute Myeloid Leukemia With Fusion Proteins. | Front Oncol | 2021 | 34540702 | PubTator, text mining | PubMed |
| Therapeutically Targeting Cancers That Overexpress FOXC1: A Transcriptional Driver of Cell Plasticity, Partial EMT, and Cancer Metastasis. | Front Oncol | 2021 | 34540690 | PubTator, text mining | PubMed |
| Anticancer Effects of I-BET151, an Inhibitor of Bromodomain and Extra-Terminal Domain Proteins. | Front Oncol | 2021 | 34540687 | PubTator, text mining | PubMed |
| Current Progress in Delineating the Roles of Pseudokinase TRIB1 in Controlling Human Diseases. | J Cancer | 2021 | 34539875 | PubTator, text mining | PubMed |
| Thymus Degeneration and Regeneration. | Front Immunol | 2021 | 34539637 | PubTator, text mining | PubMed |
| PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome. | Blood Adv | 2021 | 34529761 | PubTator, text mining | PubMed |
| Transitions in lineage specification and gene regulatory networks in hematopoietic stem/progenitor cells over human development. | Cell Rep | 2021 | 34525349 | PubTator, text mining | PubMed |
| Genotype-specific cortisol production associated with Cushing's syndrome adenoma with PRKACA mutations. | Mol Cell Endocrinol | 2021 | 34520814 | PubTator, text mining | PubMed |
| HOXA9-methylated DNA as a diagnostic biomarker of ovarian malignancy. | Biomark Med | 2021 | 34514844 | PubTator, text mining | PubMed |
| A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML. | Int J Mol Sci | 2021 | 34502319 | PubTator, text mining | PubMed |
| Reconnoitering the Role of Long-Noncoding RNAs in Hypertrophic Cardiomyopathy: A Descriptive Review. | Int J Mol Sci | 2021 | 34502285 | PubTator, text mining | PubMed |
| The Role of Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Leukemia. | J Clin Med | 2021 | 34501237 | PubTator, text mining | PubMed |
| Synthesis and Biological Activity of a Cytostatic Inhibitor of MLLr Leukemia Targeting the DOT1L Protein. | Molecules | 2021 | 34500733 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3205/papers?page=59